Esken Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in Gujarat, Gujarat, India, established in 1992.
1992 Gujarat, Gujarat, India Active
Last Updated:
Access Report
About Esken Pharmaceuticals Limited

Esken Pharmaceuticals Limited, a active public limited company, was established on 07 July 1992 in Gujarat, Gujarat, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24231GJ1992PLC017941. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹6.30 Cr and a paid-up capital of ₹1.59 Cr.

It upholds a compliant status. Employing 3 professional, Its leadership includes Pranavkumar Manilal Patel (Whole-Time Director), Ashishkumar Tribhovandas Patel (Whole-Time Director), Nigamkumar Babulal Patel (Whole-Time Director). Past directors included Manilal Kashiram Patel, Bharatkumar Manilal Patel. It holds no open charges and ₹2.84 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 322 G I D C Phase Iidediasan Mehsana, Gujarat, Gujarat, 384001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231GJ1992PLC017941

  • Registration Number

    017941

  • Incorporation Date

    07 July 1992

  • Authorized Capital

    ₹6.30 Cr

  • Paid-Up Capital

    ₹1.59 Cr

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 6.30 Cr
  • Paid Up Capital ₹ 1.59 Cr
  • Company Age 33 Year, 10 Months
  • Last Filing with ROC 31 Mar 2025
  • Satisfied Charges ₹ 2.84 Cr
  • Revenue Growth **** -51.95%
  • Profit Growth **** -74.72%
  • Ebitda **** -364.43%
  • Net Worth -46.31%
  • Total Assets -11.85%
Company report

Esken Pharmaceuticals Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Esken Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Esken Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Pranavkumar Manilal Patel Whole-Time Director 06 Jul 1997 Current
Ashishkumar Tribhovandas Patel Whole-Time Director 06 Jul 1997 Current
Nigamkumar Babulal Patel Whole-Time Director 06 Jul 1997 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 21 May 2010 Past
Pramod Abcsdd Managing Director 12 May 2015 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Esken Pharmaceuticals.

Esken Pharmaceuticals Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 51.95% decrease. The company also saw a substantial fall in profitability, with a 74.72% decrease in profit. The company's net worth observed a substantial decline by a decrease of 46.31%.

Esken Pharmaceuticals revenue growth over time
Esken Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -51.95%
*******
*******
*******
*******
Revenue from Operations
*******
 -52.43%
*******
*******
*******
*******
Total Assets
*******
 -11.85%
*******
*******
*******
*******
Profit or Loss
*******
 -74.72%
*******
*******
*******
*******
Net Worth
*******
 -46.31%
*******
*******
*******
*******
EBITDA
*******
 -364.43%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Esken Pharmaceuticals?

In 2019, Esken Pharmaceuticals had a promoter holding of 15.79% and a public holding of 84.21%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹28,400,000.00

Charges Breakdown by Lending Institutions
  • Others : 2.25 Cr
  • The Co-Operative Bank Of Mehsana Limited : 0.50 Cr
  • The Co-Op Bank Of Mehsana Ltd. : 0.09 Cr
Latest Charge Details
Date Lender Amount Status
23 May 2016 Others ₹2.25 Cr Satisfied
26 Feb 2009 The Co-Operative Bank Of Mehsana Limited ₹2.50 M Satisfied
05 Jul 2008 The Co-Operative Bank Of Mehsana Limited ₹2.50 M Satisfied
11 Jun 2007 The Co-Op Bank Of Mehsana Ltd. ₹0.90 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Esken Pharmaceuticals?

Esken Pharmaceuticals has a workforce of 3 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Esken Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Esken Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Esken Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Esken Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Esken Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was documented.

  • Charges

    The activity A charge registered on 23 May 2016 via Charge ID 100028731 with Others was fully satisfied on 03 Sep 2020. was completed.

  • Charges

    Progress on A charge with Others amounted to Rs. 2.25 Cr with Charge ID 100028731 was registered on 23 May 2016. was documented.

  • Charges

    A charge registered on 26 Feb 2009 via Charge ID 10147777 with The Co-Operative Bank Of Mehsana Limited was fully satisfied on 18 May 2016. was recorded as a recent event.

  • Charges

    Progress on A charge registered on 05 Jul 2008 via Charge ID 10112748 with The Co-Operative Bank Of Mehsana Limited was fully satisfied on 18 May 2016. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Esken Pharmaceuticals Limited?

The CIN of Esken Pharmaceuticals Limited is U24231GJ1992PLC017941.

Where is Esken Pharmaceuticals Limited headquartered?

Esken Pharmaceuticals Limited is headquartered at 322 G I D C Phase Iidediasan Mehsana, Gujarat, Gujarat, 384001.

When was Esken Pharmaceuticals Limited incorporated?

Esken Pharmaceuticals Limited was incorporated on 07 July 1992.

Who are the current directors of Esken Pharmaceuticals Limited?

The current directors of Esken Pharmaceuticals Limited are

What is the primary industry of Esken Pharmaceuticals Limited?

The primary industry of Esken Pharmaceuticals Limited is Pharma.

Is Esken Pharmaceuticals Limited a listed company?

Esken Pharmaceuticals Limited is unlisted.

What is the capital structure of Esken Pharmaceuticals Limited?

The authorized capital of Esken Pharmaceuticals Limited is ₹6.30 Cr, and the paid-up capital is ₹1.59 Cr.

What is the compliance status of Esken Pharmaceuticals Limited?

The compliance status of Esken Pharmaceuticals Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available